-
261
Regulatory mechanism of Reelin activity: a platform for exploiting Reelin as a therapeutic agent
Published 2025-01-01“…However, in recent decades, its role in the adult brain has become increasingly important, and it is now clear that diminished Reelin function is involved in the pathogenesis and progression of neuropsychiatric and neurodegenerative disorders, including schizophrenia and Alzheimer’s disease (AD). Reelin activity is regulated at multiple steps, including synthesis, posttranslational modification, secretion, oligomerization, proteolytic processing, and interactions with extracellular molecules. …”
Get full text
Article -
262
Inflammatory Fibroid Polyp in a 48-Year-Old Male: A Rare Cause of Intussusception
Published 2020-01-01“…Herein, we present a case of a 48-year-old male with a known history of schizophrenia who presented with mechanical intestinal obstruction following intussusception due to inflammatory fibroid polyp involving the proximal jejunojejunal part of the jejunum.…”
Get full text
Article -
263
N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth
Published 2016-01-01“…Highly penetrant mutations leading to schizophrenia are enriched for genes coding for N-methyl-D-aspartate receptor signaling complex (NMDAR-SC), implicating plasticity defects in the disease’s pathogenesis. …”
Get full text
Article -
264
Assessing the health implications of anticholinergic drugs in older people
Published 2025-01-01“…We propose practical guidelines for their use in clinical contexts such as dementia, schizophrenia, depression, anxiety, Parkinson’s disease, cardiovascular conditions, and urinary incontinence. …”
Get full text
Article -
265
Constrictive Pericarditis Associated with Atypical Antipsychotics
Published 2012-01-01“…Pericarditis developed in our patient with a longstanding history of schizophrenia treated with atypical antipsychotics. Pericardiectomy was undertaken, and the patient's presenting symptom of shortness of breath resolved subsequently with an uneventful postoperative course.…”
Get full text
Article -
266
Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry
Published 2011-01-01“…Society has a real need for the drugs that are no longer going to be developed for, among others, drug-resistant epilepsy, neuropathic and cancer pain, type-2 diabetes, obesity, and schizophrenia. The authors propose a radical response by the U.S. government and the National Institutes of Health to rescue these abandoned projects, and to continue selected programs for drug approval by the U.S. …”
Get full text
Article -
267
P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
Published 2016-01-01“…The findings discussed here may explain how P2Y1 receptor activation during brain injury, hypoxia, inflammation, schizophrenia, or Alzheimer’s disease leads to an impairment of cognitive processes. …”
Get full text
Article -
268
Clozapine-Induced Myocarditis: Is Mandatory Monitoring Warranted for Its Early Recognition?
Published 2014-01-01“…Clozapine is an atypical antipsychotic used for treatment resistant schizophrenia. Its potential to induce agranulocytosis is well known but it can also cause myocarditis. …”
Get full text
Article -
269
Comprehensive synthesis of mHealth interventions in psychiatry: insights from systematic, scoping, narrative reviews and content analysis
Published 2024-10-01“…Additionally, mHealth shows promise in managing substance use disorders and severe mental illnesses like schizophrenia, bipolar disorder and psychosis. Conclusion: Despite positive outcomes, challenges such as data privacy, user engagement and healthcare integration persist. …”
Get full text
Article -
270
Thiamine Deficiency in Self-Induced Refeeding Syndrome, an Undetected and Potentially Lethal Condition
Published 2014-01-01“…We describe a 25-years-old female patient with mental disorders and severe malnutrition who developed severe clinical manifestations and biochemical abnormalities characteristic of the refeeding syndrome, after restarting oral feeding on her own. Schizophrenia was later diagnosed. Increased awareness of this condition and its complications is necessary to prevent its detrimental complications.…”
Get full text
Article -
271
Cooccurrence of Darier’s Disease and Epilepsy: A Pediatric Case Report and Review of the Literature
Published 2014-01-01“…They include mood disorders, epilepsy, encephalopathy, and schizophrenia. In this study, we report a pediatric case with the cooccurrence of Darier’s disease and epilepsy. …”
Get full text
Article -
272
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
Published 2025-01-01“…Common ADEs included increased blood prolactin, galactorrhea, and schizophrenia, which was consistent with drug label. …”
Get full text
Article -
273
Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation.
Published 2025-01-01“…., bipolar disorder, schizophrenia, and other non-organic psychoses) who were prescribed a new antipsychotic between 2005 and 2017, with a 2-year follow-up to 2019. …”
Get full text
Article -
274
A 27-Month-Old Boy with Polyuria and Polydipsia
Published 2018-01-01“…Psychogenic polydipsia is a well-described phenomenon in those with a diagnosed psychiatric disorder such as schizophrenia and anxiety disorders. Primary polydipsia is differentiated from psychogenic polydipsia by the lack of a clear psychotic disturbance. …”
Get full text
Article -
275
Emerging Roles of BAI Adhesion-GPCRs in Synapse Development and Plasticity
Published 2016-01-01“…Abnormalities in synapse and spine formation and plasticity are associated with a broad range of brain disorders, including intellectual disabilities, autism spectrum disorders (ASD), and schizophrenia. Thus, elucidating the mechanisms that regulate these neuronal processes is critical for understanding brain function and disease. …”
Get full text
Article -
276
Microglial Dysregulation in Psychiatric Disease
Published 2013-01-01“…Here we summarize postmortem, animal, neuroimaging, and other evidence for microglial pathology in major depression, schizophrenia, autism, obsessive-compulsive disorder, and Tourette syndrome. …”
Get full text
Article -
277
Lessons Learned and Questions Raised by an Atypical Case of Clozapine-Induced Myocarditis
Published 2016-01-01“…A Caucasian male in his early twenties suffering from treatment resistant schizophrenia was started on clozapine. After three days he developed tachycardia, a common side effect of clozapine induction. …”
Get full text
Article -
278
The Value of Desmethylclozapine and Serum CRP in Clozapine Toxicity: A Case Report
Published 2012-01-01“…Clozapine, an atypical antipsychotic, has proved to be superior to other antipsychotics in treating patients with refractory schizophrenia. An increased plasma clozapine level above the therapeutic window may be associated with serious adverse events including paralytic ileus. …”
Get full text
Article -
279
Sword of heaven
Published 2019-12-01“…If Shakespeare editions have been slow to absorb the news from Vienna that the schizophrenia of Measure for Measure is a result not of authorial despair, but of its having been constructed by two dramatists of distinct generations and mentalities, working some sixteen years apart, they have nonetheless always registered resistance in the play to this totalitarian project of putting power on display.…”
Get full text
Article -
280
Progress on neuromodulation for treatment of mental disorders
Published 2025-01-01“…This paper summarizes the current applications of neuromodulation technique for various mental disorders, including obsessive⁃compulsive disorder, depression, Tourette's syndrome, bipolar affective disorder, autism spectrum disorder, substance dependence and schizophrenia. Additionally, it analyzes the prospects and challenges of neuromodulation technique in the treatment of mental disorders, with the aim of guiding future neuromodulation therapy for mental disorders.…”
Get full text
Article